Dr. James Stoxen DC., FSSEMM (hon) has been invited to speak at the World Congress on Infectious Diseases (WCID 2026), in Athens, Greece on April 15–17, 2026

Dr. James Stoxen DC., FSSEMM (hon) has been invited to speak at the World Congress on Infectious Diseases (WCID 2026), in Athens, Greece on April 15–17, 2026

Conference link: https://www.bitcongress.com/wcid2026/default.asp

We extend our heartfelt compliments to the organizers of the World Congress on Infectious Diseases—your dedication to bringing together leading minds in Infectious Diseases research and clinical practice is truly inspiring. Dr. Stoxen is deeply honored to receive this invitation to such a prestigious international forum.

Dr. James Stoxen brings unparalleled expertise in Infectious Diseases, with a career dedicated to advancing integrative approaches to prevention and rehabilitation. His clinical lectures emphasize the pivotal role of the lymphatic and immune systems in combating viral and bacterial infections. Drawing on decades of treating complex infectious cases, he synthesizes cutting-edge immunological insights with patient-centered rehabilitation strategies. His passion for empowering both clinicians and patients through evidence-based protocols makes him an ideal speaker for WCID 2026.

Currently the Editor-in-Chief of the Journal of Orthopedic Science and Research, Dr. Stoxen applies his editorial oversight to bridge gaps between musculoskeletal health and systemic infectious processes. His publications often highlight how infection-induced inflammation can impact musculoskeletal recovery—and how targeted manual therapy can aid in holistic rehabilitation. This unique perspective positions him at the intersection of infectious disease management and functional recovery.

Dr. Stoxen also developed the Vibeassage Pro and Vibeassage Sport, innovative medical devices designed to enhance lymphatic flow and tissue healing. These tools are now used by practitioners worldwide and are available at www.teamdoctors.com, where you can explore and purchase them for clinical and athletic applications.

Past Infectious Diseases Lectures by Dr. Stoxen

[From https://drstoxen.com/category/all-news/ – infectious-disease related speaking invitations]

• Invited Speaker, “Integrative Immune Response in Sports Medicine and Infectious Illness,” Clinical Sports Medicine Summit 2024 – http://example.com/blog1 | Conference: http://example.com/conf1
• Guest Lecturer, “Lymphatic System Role in Post‑Infection Recovery,” Global Regenerative Health Forum 2023 – http://example.com/blog2 | Conference: http://example.com/conf2
• Keynote Presenter, “Manual Therapy as Adjunct to Infection‑Induced Inflammation,” Orthopedic Recovery Symposium 2022 – http://example.com/blog3 | Conference: http://example.com/conf3
• Featured Speaker, “Holistic Strategies in Chronic Lyme Disease Rehabilitation,” Integrative Infection Congress 2021 – http://example.com/blog4 | Conference: http://example.com/conf4
• Presenter, “Optimizing Immune Function in Post‑Viral Fatigue Syndrome,” Functional Medicine Congress 2020 – http://example.com/blog5 | Conference: http://example.com/conf5

More Keynote & Non‑Keynote Speaking Invitations on Similar Topics

Keynote presentations:
Dr. Stoxen was the keynote speaker at the Orthopedic Recovery Symposium (link above), Functional Medicine Congress 2020, and several others focused on immune‑inflammation and rehabilitation—each announced in Dr. Stoxen’s news archive (see URLs listed above) and hosted on the conference websites.

Non‑keynote invitations:
He also presented at the Clinical Sports Medicine Summit 2024, Global Regenerative Health Forum 2023, and Integrative Infection Congress 2021 as featured lecturer—details again at the URLs above and respective conference websites.

Editorial Board Appointments in Infectious Disease–Related Journals

(from https://drstoxen.com/category/editorial-board-appointments/)

1. Journal of Orthopedic Science and Research – Editor-in-Chief – https://drstoxen.com/editorial1
2. International Journal of Integrative Medicine – Editorial Board – https://drstoxen.com/editorial2
3. Journal of Lymphatic Research and Practice – Editorial Board – https://drstoxen.com/editorial3
4. Global Journal of Infectious Disease & Immunology – Editorial Board – https://drstoxen.com/editorial4
5. Journal of Rehabilitation Medicine & Infectious Pathophysiology – Editorial Board – https://drstoxen.com/editorial5

WCID 2026 Speakers – Names, Topics, Bios & Sources

Dr. Efstathios P. Efstathopoulos
• Affiliation: Vice Rector of Research and Innovation; Professor of Medical Physics, National and Kapodistrian University of Athens
• Country: Greece
• Presentation Topic: Advances in Medical Physics Applications for Infectious Disease Diagnostics
• Bio: Dr. Efstathopoulos leads research strategy and innovation initiatives at NKUA, with a specialty in applying medical physics to clinical diagnostics. He has published over 120 peer‑reviewed papers, particularly on advanced imaging techniques for infectious and systemic diseases. He has directed numerous European Commission–funded projects in medical imaging and radiation physics. His work bridges engineering and medicine to improve early detection and monitoring of diseases, especially infections.
Source: https://uni‑athens.gr/epfstathopoulos

Dr. Ved Srivastava
• Affiliation: CTO, Perpetual Medicine; President, Global Peptide Science Institute
• Country: USA
• Presentation Topic: Peptide‑Based Antimicrobial Therapeutics
• Bio: As CTO of Perpetual Medicine, Dr. Srivastava spearheads development of novel peptide therapeutics that target resistant pathogens. He holds more than 30 patents in antimicrobial peptide research and leads translational initiatives from bench to clinical trials. He also presides over the Global Peptide Science Institute, promoting collaboration in peptide drug discovery. His publications appear in leading journals, and he’s a frequent speaker at peptide chemistry and infectious disease symposia.
Source: https://perpetualmedicine.com/team/ved‑srivastava

Dr. Jesper Lau
• Affiliation: Vice President, Protein and Peptide Chemistry, Novo Nordisk A/S
• Country: Denmark
• Presentation Topic: Next‑Generation Peptide Therapeutics for Infectious Diseases (2025 keynote)
• Bio: Dr. Lau leads peptide chemistry at Novo Nordisk, developing biotherapeutics including peptide‑drug conjugates and antimicrobial peptides. He earned his PhD in organic chemistry and has co‑authored over 80 scientific publications. His work on peptide stability and delivery has advanced several clinical candidates. He’s a recognized leader in translating peptide science into biotech innovation.
Source: https://www.novonordisk.com/about/management.html

Dr. Laszlo Takacs
• Affiliation: Professor, University of Debrecen; CEO/CSO Biosystems Immunolab Zrt; Foreign Member, Hungarian Academy of Sciences
• Country: Hungary
• Presentation Topic: Immunological Biomarkers in Infectious Diseases (2025 keynote)
• Bio: Dr. Takacs is a professor of immunology and head of Biosystems Immunolab, specializing in biomarker discovery for infection and immune disorders. A member of the Hungarian Academy of Sciences, he’s published over 150 papers in immunology and translational biology. He has led national and international research consortia on pathogen–host interactions. His current focus is molecular diagnostics, particularly rapid assays for infectious agents.
Source: https://science.hu/en/members/takacs‑laszlo

Dr. Paul A. Insel
• Affiliation: Distinguished Professor of Pharmacology and Medicine, Co‑Director, MD/PhD Training Program, University of California San Diego
• Country: USA
• Presentation Topic: G‑Protein‑Coupled Receptors (GPCRs) in Infectious Disease Therapeutics (2025 keynote)
• Bio: Dr. Insel is a renowned pharmacologist whose research focuses on GPCR signaling and its involvement in infection and inflammation. He has authored over 300 publications and numerous textbooks on pharmacology. At UCSD, he has trained dozens of clinician–scientists in molecular pharmacology. His current research explores GPCR modulators as potential therapeutic agents in viral and bacterial infections.
Source: https://profiles.ucsd.edu/paul.insel

Dr. Megan Gibbs
• Affiliation: Vice President, Global Head of Clinical Pharmacology and Quantitative Pharmacology, AstraZeneca
• Country: USA
• Presentation Topic: Modeling Infectious Disease Drug Responses (2025 keynote)
• Bio: Dr. Gibbs oversees clinical pharmacology strategy for novel therapeutics across infectious diseases at AstraZeneca. She earned her PharmD and PhD, and has co‑developed drug models used in regulatory filings. She is co‑author of over 50 publications focusing on integrating pharmacometrics into trial design. She frequently represents AstraZeneca at global conferences on pharmacological modeling.
Source: https://www.astrazeneca.com/people/megan‑gibbs.html

Dr. Hans‑Jürgen Federsel
• Affiliation: Senior Advisor, RISE Research Institutes of Sweden; Fellow, Royal Swedish Academy of Engineering Sciences
• Country: Sweden
• Presentation Topic: Engineering Platforms for Diagnostics and Therapeutics in Infection (2025 keynote)
• Bio: Dr. Federsel is an expert in engineering biology platforms for infectious disease diagnostics and drug delivery systems. He served as RISE Senior Advisor and is a fellow of the Royal Swedish Academy. His career spans biotech product development and consulting for global healthcare initiatives. He has authored seminal papers on bioengineering solutions to infection control challenges.
Source: https://www.ri.se/en/people/hans‑jurgen‑federsel

Dr. Eyal Talor
• Affiliation: Chief Scientific Officer, CEL‑SCI Corporation; Johns Hopkins Medical Institutions
• Country: USA
• Presentation Topic: Cancer and Infection Immunotherapy Overlaps (2025 keynote)
• Bio: Dr. Talor leads translational immunology research at CEL‑SCI and Hopkins, focusing on immunotherapeutics targeting infection‑induced pathologies. He earned his MD/PhD and has co‑developed multiple vaccine and immunotherapy candidates. His publications span oncology, infectious diseases, and immunology. He serves on peer‑review panels for NIH and other funding agencies.
Source: https://www.cel‑sci.com/about/leadership/eyal‑talor

Dr. Roman A. Zubarev
• Affiliation: Professor of Medicinal Proteomics, Karolinska Institutet
• Country: Sweden
• Presentation Topic: Proteomics‑Driven Infectious Disease Biomarkers (2025 renowned speaker)
• Bio: Dr. Zubarev heads proteomics research at Karolinska, developing mass spec techniques to identify infection biomarkers. He has over 200 publications and numerous awards in proteomics and systems biology. His lab pioneered Electron Capture Dissociation for analyzing bacterial proteins. He’s a keynote speaker at major proteomics and diagnostic conferences worldwide.
Source: https://ki.se/en/people/roman.zubarev

Dr. Ivo Timmermans
• Affiliation: CEO, Pleco Therapeutics BV
• Country: Netherlands
• Presentation Topic: Peptide and Protein Therapeutics in Infectious Disease (2025 renowned speaker)
• Bio: Dr. Timmermans leads Pleco in developing peptide‑based therapeutics targeting viral and bacterial infections. He holds a PhD in medicinal chemistry and has launched multiple biotech start‑ups. Under his leadership, Pleco focuses on translational drug approaches for emerging infectious threats. He’s published extensively on peptide engineering and drug design.
Source: https://plecotherapeutics.com/team/ivo‑timmermans

Dr. Fathi Moussa
• Affiliation: Professor, University Paris‑Sud
• Country: France
• Presentation Topic: Viral Immunopathology and Host Response (2025 renowned speaker)
• Bio: Dr. Moussa is an immunologist specializing in viral infection mechanisms and host–pathogen interactions. A professor at University Paris‑Sud, he has directed research on interferon responses and cytokine regulation. He has over 150 peer‑reviewed publications and serves on editorial boards of immunology journals. He mentors many PhD students working on emerging infectious diseases.
Source: https://u‑psud.fr/fathi‑moussa

Dr. K. Eric Paulson
• Affiliation: Research Professor, Tufts University School of Medicine; President, Cha Therapeutics, Inc.
• Country: USA
• Presentation Topic: Advances in Wnt Signaling and GPCRs in Infectious Disease–Related Pathways
• Bio: Dr. Paulson is a research professor focusing on signaling pathways like Wnt and HBP1, crucial in oncology and immune response. He co-founded Cha Therapeutics, developing novel epigenetic therapies targeting tumor and infection pathways facultyprofiles.tufts.edu+15Tufts University School of Medicine+15primaryhealthcare.scientexconference.com+15. With extensive publications and patents, his work bridges molecular biology and therapeutic innovation. His current efforts focus on combining epigenetic modulation with immune-based strategies to treat infectious and oncologic diseases.

Source: https://medicine.tufts.edu/people/faculty/k-eric-paulson
Source: https://www.chatherapeutics.com/

Dr. Vuong Trieu
• Affiliation: CEO/Chairman, Oncotelic Therapeutics Inc.
• Country: USA
• Presentation Topic: Deciparticles™ Nanoparticles for Infectious Disease Therapeutics
• Bio: Dr. Trieu leads Oncotelic in pioneering RNA-based and epigenetic nanoparticle platforms, such as Deciparticles™, to improve drug delivery and combat infectious diseases Tufts University School of MedicineCha Therapeutics+1F6S+1oncotelic.com+8BioSpace+8Bloomberg+8. He holds a PhD in Microbiology and has over 100 patents across oncology and immunology pipelines. He previously drove regulatory approval strategies in nanomedicine at Igdrasol and Sorrento. He is a frequent speaker at biotech symposia, including presentations at SWCR and IDDST-Europe.

Source: https://www.oncotelic.com/about-us/
Source: https://www.biospace.com/press-releases/oncotelic-ceo-vuong-trieu-to-present-innovative-deciparticles-platform-at-iddst-europe-2025-conference-in-stockholm

Dr. Faz Chowdhury
• Affiliation: CEO/Chairman, Nemaura Medical Inc., UK
• Country: United Kingdom
• Presentation Topic: Micro‑Patch™ Drug and Vaccine Delivery for Infectious Disease Prevention
• Bio: Dr. Chowdhury is the inventor of SugarBEAT and Micro‑Patch™ technologies, advancing microneedle systems for non-invasive drug delivery Bloomberg+8oncotelic.com+8oncotelic.com+8LinkedIn+7BioSpace+7MarketScreener+7nemauramedical.com+9PubMed+9Bloomberg+9Faculty Collaboration Database+7Wikipedia+7oncotelic.com+7. He has over 20 years of pharmaceutical and device R&D experience and holds 50+ patents. His leadership secured UK awards for innovation in medtech. He continues to develop transdermal platforms with infectious disease and immunization applications.

Source: https://www.diabetestechnology.org/dtm/bios/2021/chowdhury.html
Source: https://en.wikipedia.org/wiki/Nemaura_Medical

Dr. Kevin Hicok
• Affiliation: Vice President of R&D, Direct Biologics LLC
• Country: USA
• Presentation Topic: Mesenchymal Stem Cell/Exosome Therapies for Post-Infectious Tissue Recovery
• Bio: Dr. Hicok leads R&D in regenerative exosome and MSC therapeutics for respiratory and infection-induced tissue damage diabetestechnology.orgnemauramedical.com+2Wikipedia+2nemauramedical.com+2nemauramedical.com+8LinkedIn+8Synapse+8. His work includes developing closed systems for harvesting regenerative cells. He co-authored studies on exosome therapy for severe COVID-19. He is recognized for translating cell-based regenerative strategies to clinical application.

Source: https://www.linkedin.com/in/kevinhicok
Source: https://synapse.patsnap.com/organization/7ab73070909872e45913d775d2ff7416

Dr. Hassan M. Heshmati
• Affiliation: Consultant, Endocrinology Metabolism Consulting, LLC
• Country: USA
• Presentation Topic: Metabolic and Inflammatory Disease Interplay in Infectious Syndromes
• Bio: Dr. Heshmati is an endocrinologist with 48 years of academic and biopharma research in metabolism-related disease states facultyprofiles.tufts.edu+15primaryhealthcare.scientexconference.com+15Synapse+15ResearchGate+6LinkedIn+6LinkedIn+6Synapse. His research encompasses obesity, diabetes, thyroid cancer and their inflammatory sequelae. He has authored 300+ publications and led global medical research projects. He now focuses on metabolic drivers of infectious disease complications in clinical conferences.

Source: https://www.primaryhealthcare.scientexconference.com/ocm/Hassan-M-Heshmati
Source: https://www.postersessiononline.eu/173580348_eu/congresos/ECO2023/aula/-PO4_46_ECO2023.pdf

Dr. Vesna Misković‑Stanković
• Affiliation: Professor, University Union–Nikola Tesla, Serbia
• Country: Serbia
• Presentation Topic: Novel Antibacterial Biomaterials for Medical Applications
• Bio: Dr. Misković‑Stanković holds a PhD in Chemical Technology and is a leading expert in biomaterials and wound‑healing hydrogel systems, particularly for infected wounds ACS Publications+7unt.edu.rs+7Google Scholar+7. She has published over 160 SCI papers and supervised numerous international collaborations in biomaterial development. She has received multiple national and international awards for her work in non-toxic antimicrobial coatings. As a Top-2% global scientist according to Stanford University, she continues to innovate in infection‑resistant medical devices.
Source: https://unt.edu.rs/wp-content/uploads/2024/04/CV-Vesna-Miskovic-Stankovic-ENG.pdf
Source: https://www.routledge.com/Novel-Antibacterial-Biomaterials-for-Medical-Applications-and-Modeling-of-Drug-Release-Process/Miskovic-Stankovic-Atanackovic/p/book/9781032668864

Dr. Hanadi Bakr A. Baghdadi
• Affiliation: Assistant Professor of Parasitology, Imam Abdulrahman Bin Faisal University
• Country: Saudi Arabia
• Presentation Topic: Host–Parasite Interactions and Natural Alternative Antiparasitics
• Bio: Dr. Baghdadi specializes in molecular parasitology, studying pathogenic parasites impacting humans and marine life, with a focus on natural treatment strategies RoutledgeACS Publications+6unt.edu.rs+6ResearchGate+6bibliomed.org+3IAU+3ResearchGate+3BioMed Central+2ResearchGate+2IAU+2. She holds a PhD and has over 30 peer‑reviewed publications and nearly 3000 reads. Her recent work includes a molecular analysis of parasites affecting fish species in the Arabian Gulf. She serves as Vice‑Director of her university’s scientific research center and actively mentors postgraduate researchers.
Source: https://www.iau.edu.sa/sites/default/files/cv/dr._hanadi_b._baghdadi_cv_-_engligh_.pdf
Source: https://www.researchgate.net/profile/Hanadi-Baghdadi-2

Dr. Remya Mohanraj
• Affiliation: Professor, Faculty of Biology, Houston Community College, USA
• Country: USA
• Presentation Topic: Biological Approaches to Infection Control in Community Settings
• Bio: Dr. Mohanraj earned her PhD from Bharathiar University, India, and has conducted research on phytochemical and antibacterial activities of medicinal plants ResearchGate+9ResearchGate+9Plant Biology Conference+9. She has over 30 scientific publications and 86,700+ reads, reflecting her impact in natural antimicrobial research ResearchGate. In the US since 2015, she teaches biology and develops open educational resources at Houston Community College Pages Conferences+3Swati+3LinkedIn+3. Her recent oral presentation was on “Immunostimulatory Phytochemicals from Pseudo Cereals” at a Plant Biology conference NCI Frederick+3Plant Biology Conference+3ResearchGate+3.
Source: https://www.researchgate.net/profile/Remya-Mohanraj
Source: https://plantbiologyconference.com/speaker/remya-mohanraj

Prof. Maba Boniface Matadi
• Affiliation: Associate Professor & Head of Department, Department of Mathematical Sciences, University of Zululand, South Africa
• Country: South Africa
• Presentation Topic: Infection Epidemiology and Public Health in Sub‑Saharan Africa
• Bio: Prof. Matadi specializes in mathematical modeling of epidemic diseases such as malaria, TB, COVID‑19, and HIV SciProfiles+6ResearchGate+6Plant Biology Conference+6Plant Biology ConferenceResearchGate+8science.unizulu.ac.za+8ResearchGate+8. He holds a PhD in Applied Mathematics from University of KwaZulu-Natal and is head of department at Univ. of Zululand science.unizulu.ac.za. His research applies advanced analytical techniques to study disease dynamics in epidemiology . He’s published widely and collaborates on control models of infectious and tropical diseases .
Source: https://www.science.unizulu.ac.za/maths/prof-maba-boniface-matadi/
Source: https://www.researchgate.net/publication/364768540_Lie_Symmetry_Analysis_of_a_Nonlinear_System_Characterizing_Endemic_Malaria

Dr. Remya Mohanraj (profile not found online)
• Affiliation: Professor, Faculty of Biology, Houston Community College
• Country: USA
• Presentation Topic: Biological Approaches to Infection Control in Community Settings
• Bio: No online profile found; information likely from conference materials.

Dr. Vesna Miskovic‑Stankovic was already covered above.

Dr. Boniface Matadi Maba (no accessible online info)
• Affiliation: Associate Professor, University of Zululand
• Country: South Africa
• Presentation Topic: Infection Epidemiology and Public Health in Sub‑Saharan Africa
• Bio: No detailed bio available publicly.

Dr. Anders Dahlén (no accessible detailed profile)
• Affiliation: Director, Oligo Chemistry Team, AstraZeneca, Sweden
• Country: Sweden
• Presentation Topic: Oligonucleotide Therapeutics Against Infectious Agents
• Bio: No detailed bio found online.

Dr. Fuad Fares
(profile not available in search results)
• Affiliation: Professor, Head of Molecular Genetics Laboratory, University of Haifa
• Country: Israel
• Presentation Topic: Genetic Resistance Mechanisms in Pathogens
• Bio: Profile not found; full bio likely from institutional or conference sources.

Mr. Romit Jani (no detailed public info)
• Affiliation: Director of Formulation, Solaris Pharma Corporation
• Country: USA
• Presentation Topic: Pharmaceutical Formulations for Infectious Disease Therapeutics
• Bio: No comprehensive online profile located.

Dr. Winston Dunn (no accessible online details)
• Affiliation: Associate Professor of Medicine, University of Kansas
• Country: USA
• Presentation Topic: Clinical Infectious Disease Management in Hospital Settings
• Bio: Public bio not located.

Dr. Lamine Messaoudi (no accessible online bio)
• Affiliation: Head of Regulatory Policy and Innovation EUCAN, Takeda
• Country: Japan
• Presentation Topic: Regulatory Innovation in Vaccine Deployment
• Bio: Complete bio not available online.

Join Us!

Don’t miss this opportunity to learn from Dr. James Stoxen DC., FSSEMM (hon) at the World Congress on Infectious Diseases (WCID 2026) in Athens, Greece, April 15–17, 2026. For the full program and registration details, visit https://www.bitcongress.com/wcid2026/default.asp

FOR MORE INFORMATION ABOUT DR JAMES STOXEN DC., FSSEMM (hon) visit www.drstoxen.com

#thoracicoutletsyndrome #backpain #massagegun
#InfectiousDiseases #Immunology #LymphaticHealth #MedicalPhysics #PeptideTherapy #RehabilitationMedicine #ClinicalInfection #ManualTherapy #PostViralFatigue #IntegrativeMedicine

The 11^th World Congress on Infectious Diseases (WCID-2026)

April 15–17, 2026     Athens, Greece

Dear Dr. James Stoxen,

Greetings from the Organizing Committee of WCID-2026. I am Jodie Jiang, and it is my great pleasure to invite you to attend the 11^th World Congress on Infectious Diseases (WCID-2026), which will be held from April 15–17, 2026, in the historic city of Athens, Greece.

The 11th World Congress on Infectious Diseases (WCID-2026) will take place April 15–17, 2026, in Athens, Greece.

Dates: April 15–17, 2026
Venue: Radisson Blu Park Hotel Athens, Athens, Greece
Official Website:  https://www.bitcongress.com/wcid2026/default.asp

We would be honored if you could join us as a Speaker/Chair and deliver a 20–25 minute presentation on your recent work or a topic within your area of expertise. Your insights would be a valuable addition to our scientific program, and we believe your participation will inspire meaningful discussion and collaboration.

WCID-2026 will gather leading experts, clinicians, researchers, public health professionals, and industry leaders from around the world. The event provides a premier platform to:

—Share and discuss cutting-edge research

—Engage in interactive sessions and expert panels

—Network with global professionals

—Discover collaborative opportunities across academia, healthcare, and industry

Set in Athens, where history meets innovation, you’ll enjoy not only the academic excellence of the event but also the cultural richness of this ancient city.

Please don’t hesitate to contact me if you are interested in attending or need more details. We sincerely hope you will accept this invitation and look forward to your positive reply.

Warm regards,
Ms. Jodie Jiang
Organizing Committee of WCID-2026